FDA Clearance Tracker · K232417
MR Q; MR Q SUPINE; MR Q SLT
Last checked: Nov 20, 2026Latest source record: Jan 25, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jan 25, 2024
Substantially Equivalent
Time to decision
167 days
Received Aug 11, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232417
- Device name
- MR Q; MR Q SUPINE; MR Q SLT
- Applicant
- Meridian AG
- Applicant location
- Thun, CH
- Received
- Aug 11, 2023
- Decided
- Jan 25, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Laser, Ophthalmic (HQF)
- Device class
- Class II
- Regulation
- 21 CFR 886.4390
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code HQF. The earliest in FDA's data is K782065, decided Dec 28, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232417
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Meridian AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231011 · Decided Sep 12, 2023 · 155 days after receipt
Device type: Laser, Ophthalmic (HQF) · Ophthalmology
- MICRORUPTOR 6510(k)
K160677 · Decided May 19, 2017 · 435 days after receipt
Device type: Powered Laser Surgical Instrument (GEX) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.